Suchergebnisse - "Gupta, Neeraj"

PubPharm (651)

51

Brigatinib pharmacokinetics in patients with chronic hepatic impairment

enthalten in: Investigational new drugs | 2023

von Hanley, M. | Kerstein, D. | Tugnait, M. | +4

52

Brigatinib pharmacokinetics in patients with chronic hepatic impairment

enthalten in: Investigational new drugs | 2023

von Hanley, M. | Kerstein, D. | Tugnait, M. | +4

53

Brigatinib pharmacokinetics in patients with chronic hepatic impairment

enthalten in: Investigational new drugs | 2023

von Hanley, M. | Kerstein, D. | Tugnait, M. | +4

54

A phase I, first-in-human study of TAK-164, an antibody-drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Kim, R. | Leal, A. | Parikh, A. | +9

ErratumIn: Cancer Chemother Pharmacol. 2023 Mar 26;:. - PMID 36967405

55

Population Pharmacokinetics of Mivavotinib (TAK-659), a Dual Spleen Tyrosine Kinase and FMS-Like Tyrosine Kinase 3 Inhibitor, in Patients With Advanced Solid Tumors or Hematologic Malignancies

enthalten in: Journal of clinical pharmacology | 2023

von Li, C. | Watson, K. | Wang, S. | +2

56

Systematic rotation versus continuous application of ‘nasal prongs’ or ‘nasal mask’ in preterm infants on nCPAP: a randomized controlled trial

enthalten in: European journal of pediatrics | 2023

von Gautam, G. | Gupta, N. | Sasidharan, R. | +4

57

Correction to: A phase I, first-in-human study of TAK-164, an antibody–drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Kim, R. | Leal, A. | Parikh, A. | +9

58

Effect of Pevonedistat, an Investigational NEDD8-Activating Enzyme Inhibitor, on the QTc Interval in Patients With Advanced Solid Tumors

enthalten in: Clinical pharmacology in drug development | 2023

von Zhou, X. | Richardson, D. | Dowlati, A. | +10

59

Asia-Inclusive Clinical Research and Development Enabled by Translational Science and Quantitative Clinical Pharmacology : Toward a Culture That Challenges the Status Quo

enthalten in: Clinical pharmacology and therapeutics | 2023

von Venkatakrishnan, K. | Gupta, N. | Smith, P. | +5

60

A phase I, first-in-human study of TAK-164, an antibody–drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Kim, R. | Leal, A. | Parikh, A. | +9